Evidence map›Paper›PMID 39040855›Full record

ArticleHeliyon2024

Yanjun Wang, Xiping He, Qiang Liu, Saeid Razmjooy

RetractedAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

  • Retraction · 2026-01-22Author Unresponsive · Concerns/Issues about Referencing/Attributions · Investigation by Journal/Publisher · Unreliable Results and/or Conclusions ·
5 · Who and what money

Authors and funding

4 authors.

Yanjun WangCollege of Marine Science and Environment, Dalian Ocean University, Dalian, 116023, China.
Xiping HeSchool of Physics and Information Technology, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China.
Qiang LiuSchool of Physics and Information Technology, Shaanxi Normal University, Xi'an, 710119, Shaanxi, China.
Saeid RazmjooyDepartment of Engineering, University of Mohaghegh Ardabili, Ardabil, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HRES (Hybrid Renewable Energy Systems) has been designed because of the increasing demand for environmentally friendly and sustainable energy. In this study, an Improved Subtraction-Average-Based Optimizer (ISABO) is presented for optimizing the HRES system by wind power, fuel cells, and solar energy. The suggested approach, by introducing adaptive mechanisms and enhancing processes, improves the performance of the traditional subtraction-average-based optimization. Optimization aims to provide reliable and efficient energy while lowering system expenses. The efficacy of ISABO is evaluated for this goal and compared with other optimization techniques. According to the findings, The ISABO algorithm, when equipped with adaptive mechanisms, surpasses conventional optimization techniques by achieving a 12 % decrease in Net Present Cost (NPC) and Levelized Cost of Electricity (LCOE) along with a 45 % cost reduction in electrolyzers. Through simulations, it has been shown that the ISABO algorithm ensures the lowest average NPC at $1,357,018.15 while also upholding system reliability with just a 0.8 % decline in Load Point Supply Probability (LPSP) in the event of a PV unit failure. This research validates that hybrid PV/wind/fuel cell systems present superior cost-effectiveness and reliability, thereby opening doors for more economical renewable energy solutions. The study reveals hybrid PV/wind/fuel cell systems are more cost-effective than purely wind, PV, or fuel cell systems. This advancement in HRES design and optimization techniques will enable more cost-effective renewable energy options.

Indexed as

HOMERHybrid renewable energy systems (HRES)Improved subtraction-average-based optimizer (ISABO)PVSustainable energy

Identifiers

PMID39040855
PMCPMC11262582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.